Healthcare Triangle (HCTI) Fundamental Analysis: Revenue, Earnings & Valuation

3.56 / 10

Netural

The fundamental profile is concerning, rated 3.6/10. Key weaknesses include low revenue-to-market value (-0.4239) and negative return on assets (-57.04%), while inventory turnover days (232.28) and days sales outstanding (44.59) indicate operational inefficiencies. Only Net income-to-revenue and inventory turnover show relative strengths, but they are insufficient to offset broader issues.

Analysis Checks(7/10)

Revenue-MV

Value-0.42

Score1/3

Weight0.81%

1M Return0.65%

Days sales outstanding

Value44.59

Score2/3

Weight2.58%

1M Return1.73%

Profit-MV

Value0.46

Score2/3

Weight7.97%

1M Return6.09%

Net income-Revenue

Value-0.17

Score3/3

Weight7.67%

1M Return5.64%

PB-ROE

Value0.53

Score2/3

Weight8.69%

1M Return6.63%

Rate of return on total assets (%)

Value-57.04

Score1/3

Weight1.40%

1M Return0.99%

Annualized return on total assets (%)

Value-76.06

Score1/3

Weight1.40%

1M Return0.99%

Asset-MV

Value-0.50

Score2/3

Weight58.69%

1M Return30.84%

Inventory turnover days

Value232.28

Score3/3

Weight2.18%

1M Return1.44%

Cash-MV

Value-0.07

Score2/3

Weight8.60%

1M Return6.93%

Is HCTI fundamentally strong?

HCTI scores 3.56/10 on fundamentals and holds a Fair valuation at present. Backed by its -275.36% ROE, -48.84% net margin, -0.26 P/E ratio, 0.19 P/B ratio, and 82.03% earnings growth, these metrics solidify its Netural investment rating.